The preferred and most widely examined among the selective androgen receptor modulators (SARMs), Ostarine —also called MK-2866, GTX 024, or Enobosarm —arrived about the scene again from the late nineteen nineties being an experimental treatment for osteoporosis and specific disorders that bring about insulin resistance, muscle throwing away, an